Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.

Rubina MulchandaniTanica LyngdohAshish Kumar Kakkar

Published in: European journal of clinical investigation (2020)

Severe COVID-19 is characterized by significantly increased levels of pro-inflammatory cytokines and reduced T lymphocytes. Well-designed and adequately powered prospective studies are needed to amplify the current evidence and provide definitive answers to dilemmas regarding timing and type of anti-COVID-19 therapy particularly in severe patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
early onset
respiratory syndrome coronavirus
prognostic factors
stem cells
patient reported outcomes
mesenchymal stem cells
radiation therapy
locally advanced